In this episode of A Moment in Health, Dr. Ashish Jha highlights that 66% of U.S. physicians now report using AI in their clinical practice, reflecting the technology’s rapid adoption across billing, documentation, and patient care. He reviews a new JAMA Network Open study showing that people with type 2 diabetes and opioid use disorder who took semaglutide (Ozempic) had roughly half the risk of opioid overdose compared to those on other diabetes medications, adding to growing evidence that GLP-1 drugs may help reduce addictive behaviors. Dr. Brendan Saloner, Professor of Health Services, Policy and Practice at the Brown University School of Public Health, joins to outline three key policy priorities for curbing opioid overdose deaths.

Dr. Jha discusses:

• Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder — JAMA Network Open

About the Guest

Dr. Brendan Saloner is the Donald G. Millar Professor of Alcohol and Addiction Studies in the Department of Health Services, Policy, and Practice at Brown University. One strand of his research focuses on access and quality of care for people with mental health and substance use disorders. A second strand of his research focuses specifically on health care for people in the criminal legal system. At Johns Hopkins University before joining Brown, he co-led the evaluation team for the Bloomberg Overdose Prevention Initiative, a $120 million investment in overdose reduction focused on seven states.

About the Host

Dr. Ashish K. Jha is the dean of the Brown University School of Public Health.

Music by Katherine Beggs, additional music by Lulu West and Maya Polsky